Nicholas Kalogeras has been working in the field since 2015. Nicholas began their career at Bausch + Lomb as an Internal Quality Auditor and Laboratory Technician. In 2019, they moved to NeoGenomics Laboratories as a Lead Internal Auditor. In 2021, they were hired by CTI Clinical Trial and Consulting Services as a Quality Assurance Manager. Currently, they are employed at Vanguard Clinical, Inc. in the same role.
Nicholas Kalogeras attended the University of South Florida from 2011 to 2015, where they earned a Bachelor of Science in Chemistry.
March 1, 2023 - present
December, 2022
Associate Director Quality Assurance at NiKang Therapeutics
Associate Director Quality Assurance at Agenus
Associate Director Quality Assurance at Astellas Gene Therapies
Associate Director Quality Assurance at Atara Biotherapeutics
Associate Director Quality Assurance at KBI Biopharma